Paul, Weiss, Rifkind, Wharton & Garrison advised Rocket Companies on the transaction, and Fenwick & West advised Redfin. Rocket Companies (NYSE: RKT), the Detroit-based fintech platform...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Maze Therapeutics in the offering, and Davis Polk & Wardwell represented the underwriters. Maze Therapeutics, Inc. (Nasdaq: MAZE) announced its upsized initial...
You must be a Standard 1 Year member to access this content.
Fenwick & West is representing Smartsheet on the transaction, while Kirkland & Ellis and Simpson Thacher & Bartlett are representing Blackstone and Vista Equity Partners. Smartsheet...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis is representing Vista Equity Partners in the transaction, and Fenwick & West is representing Model N. Vista Equity Partners, which announced its definitive...
You must be a Standard 1 Year member to access this content.
Fenwick & West and Goodwin Procter represented Gritstone bio, Inc. in the offering, and Cooley represented the underwriters. Gritstone bio, Inc. (Nasdaq: GRTS) announced the pricing of...
You must be a Standard 1 Year member to access this content.
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Achieve Life Sciences, while Sullivan & Worcester represented Lake Street Capital Markets, LLC and JonesTrading Institutional Services LLC on the transaction. Achieve...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Achieve Life Science, while Sullivan & Worcester represented Lake Street Capital Markets in the transaction. Achieve Life Sciences, Inc. (Nasdaq: ACHV), a...
You must be a Standard 1 Year member to access this content.
Fenwick & West is representing Veracyte in the transaction, and Meitar is representing C2i Genomics. Veracyte, Inc. (Nasdaq: VCYT) announced it has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher LLP is serving as legal counsel to Neurogene Inc. and Fenwick & West LLP is serving as legal counsel to Neoleukin Therapeutics,...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
You must be a Standard 1 Year member to access this content.
Fenwick represented Aceragen on the deal, Morgan Lewis advised Idera Pharmaceuticals. Aceragen, a privately-held biotechnology company addressing rare, orphan pulmonary and rheumatic diseases for which there...
You must be a Standard 1 Year member to access this content.
